Two isoforms of tissue transglutaminase mediate opposing cellular fates
暂无分享,去创建一个
[1] K. Mehta,et al. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells , 2006, Oncogene.
[2] R. Graham,et al. Mutation of a Critical Arginine in the GTP-binding Site of Transglutaminase 2 Disinhibits Intracellular Cross-linking Activity* , 2006, Journal of Biological Chemistry.
[3] H. Yamaguchi,et al. Tissue Transglutaminase Serves as an Inhibitor of Apoptosis by Cross-Linking Caspase 3 in Thapsigargin-Treated Cells , 2006, Molecular and Cellular Biology.
[4] M. Chicoine,et al. Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas , 2005, Molecular Cancer Therapeutics.
[5] L. Fésüs,et al. Transglutaminase 2 in the balance of cell death and survival , 2005, FEBS letters.
[6] C. Khosla,et al. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. , 2005, Chemistry & biology.
[7] R. Cerione,et al. Augmentation of Tissue Transglutaminase Expression and Activation by Epidermal Growth Factor Inhibit Doxorubicin-induced Apoptosis in Human Breast Cancer Cells* , 2004, Journal of Biological Chemistry.
[8] R. Cerione,et al. Activation of the Ras-ERK Pathway Inhibits Retinoic Acid-induced Stimulation of Tissue Transglutaminase Expression in NIH3T3 Cells* , 2003, The Journal of Biological Chemistry.
[9] P. Thibault,et al. Identification of differentially expressed proteins in human glioblastoma cell lines and tumors , 2003, Glia.
[10] Soo-Youl Kim,et al. Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] Robert M. Graham,et al. Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.
[12] Rita Casadio,et al. Transglutaminases: nature's biological glues. , 2002, The Biochemical journal.
[13] S. Hersch,et al. Therapeutic Effects of Cystamine in a Murine Model of Huntington's Disease , 2002, The Journal of Neuroscience.
[14] G. Melino,et al. ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease , 2002, Cell Death and Differentiation.
[15] R. Cerione,et al. Tissue Transglutaminase Protects against Apoptosis by Modifying the Tumor Suppressor Protein p110 Rb* , 2002, The Journal of Biological Chemistry.
[16] K. Santacruz,et al. Injury‐induced ‘switch’ from GTP‐regulated to novel GTP‐independent isoform of tissue transglutaminase in the rat spinal cord , 2002, Journal of neurochemistry.
[17] G. Johnson,et al. Tissue transglutaminase differentially modulates apoptosis in a stimuli‐dependent manner , 2002, Journal of neurochemistry.
[18] Sawsan Youssef,et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine , 2002, Nature Medicine.
[19] K. Santacruz,et al. Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration , 2002, Neurochemistry International.
[20] R. Cerione,et al. Effects of Tissue Transglutaminase on Retinoic Acid-induced Cellular Differentiation and Protection against Apoptosis* , 2001, The Journal of Biological Chemistry.
[21] G. Johnson,et al. Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells , 2001, Neuroscience.
[22] C. Rodolfo,et al. Inhibition of “Tissue” Transglutaminase Increases Cell Survival by Preventing Apoptosis* , 1999, The Journal of Biological Chemistry.
[23] R. Ferrante,et al. Tissue Transglutaminase Is Increased in Huntington's Disease Brain , 1999, Journal of neurochemistry.
[24] Soo-Youl Kim,et al. Differential Expression of Multiple Transglutaminases in Human Brain , 1999, The Journal of Biological Chemistry.
[25] D. Price,et al. Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Green,et al. Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. , 1998, Molecular cell.
[27] R. Powers,et al. Transglutaminase activity is increased in Alzheimer's disease brain , 1997, Brain Research.
[28] O. Eizenberg,et al. Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes* , 1997, The Journal of Biological Chemistry.
[29] R. Cerione,et al. Biochemical Effects of Retinoic Acid on GTP-binding Protein/Transglutaminases in HeLa Cells , 1996, The Journal of Biological Chemistry.
[30] G. Melino,et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells , 1994, Molecular and cellular biology.
[31] R. Gonzales,et al. A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue. , 1992, The Journal of biological chemistry.
[32] M. Saraste,et al. FEBS Lett , 2000 .